Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Immunity|January 19, 2010
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patientsPaul A Blair, Lina Yassin Noreña, Fabian Flores-Borja, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Novel suppressive function of transitional 2 B cells in experimental arthritisJamie G Evans, Karina A Chavez-Rueda, Ayad Eddaoudi, et al.Biorxiv : the Preprint Server for Biology|February 23, 2026
Elevated ferritin as a companion biomarker of myeloid-driven inflammation in RNP/Sm co-positive, treatment-resistant SLE endotypeMuhammad Ra Shipa, Claire Beesley, Daniel McClusky, et al.The Journal of Experimental Medicine|January 20, 2005
Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cellsQiang Pan-Hammarström, Anne-Marie Jones, Aleksi Lähdesmäki, et al.BMJ Open|December 19, 2019
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trialAlexis Jones, Patrick Muller, Caroline J Dore, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient miceHelen Ferry, Paul K Potter, Tanya L Crockford, et al.Arthritis and Rheumatism|August 9, 2003
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritisGeraldine Cambridge, Maria J Leandro, Jonathan C W Edwards, et al.Proceedings of the National Academy of Sciences of the United States of America|December 13, 2002
The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in miceJeremy S Brown, Tracy Hussell, Sarah M Gilliland, et al.Frontiers in Immunology|August 22, 2017
Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF TherapyRachel Byng-Maddick, Carolin T Turner, Gabriele Pollara, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2011
Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cellsNatalie A Carter, Rita Vasconcellos, Elizabeth C Rosser, et al.Pageof 7